| P50 | author | Oluseyi Oniyangi | Q110605842 |
| P2093 | author name string | Damian H Cohall | |
| P2860 | cites work | Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease | Q24188084 |
| | Phytomedicines (medicines derived from plants) for sickle cell disease | Q24201601 |
| | Phytomedicines (medicines derived from plants) for sickle cell disease | Q24234577 |
| | Malaria chemoprophylaxis in sickle cell disease | Q24244348 |
| | Measuring inconsistency in meta-analyses | Q27860655 |
| | Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 |
| | Malevolent ogbanje: recurrent reincarnation or sickle cell disease? | Q28210385 |
| | In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent | Q28213058 |
| | Meta-analyses involving cross-over trials: methodological issues | Q29620304 |
| | Hydroxyurea for sickle cell disease | Q34281892 |
| | The presentation, management and prevention of crisis in sickle cell disease in Africa | Q38617805 |
| | Medicinal plants in Mozambique and their popular use. | Q39773086 |
| | Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. | Q40818615 |
| | Effect of niprisan on single oral dose pharmacokinetics of paracetamol in rats. | Q42663199 |
| | Green tea extract and aged garlic extract inhibit anion transport and sickle cell dehydration in vitro | Q43611949 |
| | Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with Sickle Cell Disorder | Q43714655 |
| | Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease | Q44595941 |
| | Effect of cajaminose from cajanus cajan on gelation and oxygen affinity of sickle cell haemoglobin | Q46181648 |
| | The Reversion of Sickled Cells by Cajanus cajan | Q46243111 |
| | Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia | Q46395706 |
| | The kinetics of reversal of pre-sickled erythrocytes by the aqueous extract of Cajanus cajan seeds | Q46419914 |
| | The in vitro effects of griffonin and ouabain on erythrocyte sodium content obtained from normal subjects and sickle cell patients | Q47321289 |
| | Malaria and sickle-cell disease | Q50238535 |
| | Effect of Zanthoxylum xanthoxyloides and some substituted benzoic acids on glucose-6-phosphate and 6-phosphogluconate dehydrogenases in Hbss red blood cells. | Q50688330 |
| | Mortality in sickle cell disease. Life expectancy and risk factors for early death. | Q55065788 |
| | Antisickling activity of hydroxybenzoic acids in Cajanus cajan | Q67584194 |
| | Management of patients with sickle cell disease | Q73732175 |
| | In vitro antisickling activity of a rearranged limonoid isolated from Khaya senegalensis | Q77413183 |
| | Heart disease and race | Q95812561 |
| P921 | main subject | sickle-cell disease | Q185034 |
| P577 | publication date | 2015-04-06 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Phytomedicines (medicines derived from plants) for sickle cell disease | |